AI assistant
Personalis, Inc. — Director's Dealing 2021
Aug 10, 2021
32721_dirs_2021-08-10_8a252613-cdad-4121-bc40-0aa511aa85c4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Personalis, Inc. (PSNL)
CIK: 0001527753
Period of Report: 2021-08-06
Reporting Person: Chen Richard (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-06 | Common Stock | M | 15564 | $0.00 | Acquired | 102413 | Direct |
| 2021-08-06 | Common Stock | M | 15564 | $21.18 | Disposed | 86849 | Direct |
| 2021-08-06 | Common Stock | S | 4436 | $21.22 | Disposed | 82413 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-06 | Stock Option (Right to Buy) | $1.84 | M | 9618 | Disposed | 2023-11-13 | Common Stock (9618) | Direct |
| 2021-08-06 | Stock Option (Right to Buy) | $0.44 | M | 5946 | Disposed | 2022-03-07 | Common Stock (5946) | Direct |
Footnotes
F1: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,331 shares of Common Stock acquired on October 30, 2020 and 538 shares of Common Stock acquired on April 30, 2021.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person.
F3: The weighted average sale price for the transaction reported was $21.18, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4: The weighted average sale price for the transaction reported was $21.22, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F5: The Shares subject to the option are fully vested and exercisable.